miRBiT: a rules-based single-sample serum miRNA classifier for pan-cancer detection with multi-cohort validation
Briefings in Bioinformatics · 01.03.2026 · 27 (2)
DOI: 10.1093/bib/bbag189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 25.04.2026. Verfasst von Pandikannan Krishnamoorthy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Laboratory of Immunology and Infectious Disease Biology, Indian Institute of Science Education and Research (IISER…. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Prime Minister's Research Fellowship, India.
Abstract (Originalsprache)
Liquid biopsy offers a minimally invasive approach to early cancer diagnosis. MicroRNAs (miRNAs) are small, non-coding RNAs showing excellent diagnostic potential due to their stability and dysregulation upon different physiological conditions. However, existing miRNA-based cancer classifiers rely on cohort-based comparisons, limiting their clinical utility. Extensive analyses in this study present miRNA binary trend (miRBiT), a miRNA rules-based single-sample classifier, trained on 16,190 samples, tested across nine independent datasets, and further validated on 8 distinct disease cohorts. miRBiT utilizes miRNA expression signatures at an intra-sample level to classify ‘cancer’ and ‘non_cancer’ samples, including healthy and other diseases with high sensitivity and specificity, enabling personalized predictions. Additionally, an interactive web application, miRBiT Explorer serum miRNA expression resource, is developed to visualize and validate serum miRNA expression patterns in 46,349 samples. This study highlights the potential of miRNAs in robust cancer classification, enabling personalized, minimally invasive cancer screening and early detection at an unprecedented scale.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Laboratory of Immunology and Infectious Disease Biology, Indian Institute of Science Education and Research (IISER) Bhopal, Bhopal Bypass Road, Bhauri, Bhopal-462066, Madhya Pradesh, I…
- Department of Otorhinolaryngology (ENT) - Head & Neck Surgery, All India Institute of Medical Sciences (AIIMS), Bhopal, Saket Nagar, Bhopal-462020, Madhya Pradesh, India.
- Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), Bhopal, Saket Nagar, Bhopal-462020, Madhya Pradesh, India.
- Department of Radiation Oncology, All India Institute of Medical Sciences (AIIMS), Bhopal, Saket Nagar, Bhopal-462020, Madhya Pradesh, India.
- Laboratory of Host Defense, WPI Immunology, Frontier Research Centre, Osaka University, Osaka 5650871, Japan.
ORCID-Profile: Himanshu Kumar
Förderung
- Prime Minister's Research Fellowship, India
Zitieren
APA
Krishnamoorthy, P., Parthasarathy, M., Das, N., Raj, A. S., Behera, G., Kumar, A., Gupta, V., Das, S., & Kumar, H. (2026). miRBiT: a rules-based single-sample serum miRNA classifier for pan-cancer detection with multi-cohort validation. Briefings in Bioinformatics, 27(2). https://doi.org/10.1093/bib/bbag189
Vancouver
Krishnamoorthy P, Parthasarathy M, Das N, Raj AS, Behera G, Kumar A, et al. miRBiT: a rules-based single-sample serum miRNA classifier for pan-cancer detection with multi-cohort validation. Briefings in Bioinformatics. 2026;27(2). doi:10.1093/bib/bbag189
BibTeX
@article{Krishnamoorthy2026,
author = {Krishnamoorthy, Pandikannan and Parthasarathy, Madhavan and Das, Nilanjana and Raj, Athira S and Behera, Ganakalyan and Kumar, Ashok and Gupta, Vikas and Das, Saikat and Kumar, Himanshu},
title = {miRBiT: a rules-based single-sample serum miRNA classifier for pan-cancer detection with multi-cohort validation},
journal = {Briefings in Bioinformatics},
year = {2026},
volume = {27},
number = {2},
doi = {10.1093/bib/bbag189}
}
EUVIMED